Resources
Address the complexities of hyperkalemia management
Veltassa® - the comprehensive solution for hyperkalemia.
Consistent and sustained around the clock treatment for hyperkalemia in adults
Discover the mechanism by which Veltassa® significantly reduces serum potassium.
Outcomes: The SEEK2 Study
Find out more about why Veltassa® was associated with a lower risk of morbidity and mortality than SZC.3
Outcomes: The Veteran Study
Discover the long-term data - Veltassa® was associated with a lower risk of all-cause mortality among patients with CKD and hyperkalemia.2
Veltassa® - an option for patients who cannot tolerate even a small increase in Na+
Explore how Veltassa® differs to other traditional hyperkalemia treatments.
Veltassa® - One simple step to overall K+ control
Download the key summary to Veltassa® benefits.
Veltassa® offers easy and convenient once-daily dosing
Learn the simple steps to taking Veltassa®.
References & footnotes
References
- Veltassa UAE SmPC. Veltassa KSA SmPC.
- Obi Y, et al. Long-term Patiromer Use and Outcomes Among US Veterans With Hyperkalemia and CKD: A Propensity-Matched Cohort Study. Kidney Med. 2023;6(1):100757.
- Desai NR, et al. The Association of Heart Failure and Edema Events between Patients Initiating Sodium Zirconium Cyclosilicate or Patiromer. Kidney360. 2024;5(12):1835–43.